Evidence map›Paper›PMID 22537567›Full record

ArticleSchizophrenia research2012

An odor-specific threshold deficit implicates abnormal cAMP signaling in youths at clinical risk for psychosis.

Vidyulata Kamath, Paul J Moberg, Monica E Calkins, Karin Borgmann-Winter, Catherine G Conroy, Raquel E Gur, Christian G Kohler, Bruce I Turetsky

Open access · greenAbstract read
In one paragraph

Article in Schizophrenia research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Olfaction in the psychosis prodrome: electrophysiological and behavioral measures of odor detection.International journal of psychophysiology : official journal of the International Organization of Psychophysiology · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Vidyulata KamathNeuropsychiatry Section, Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. kamathv@upenn.edu
Paul J Moberg
Monica E Calkins
Karin Borgmann-Winter
Catherine G Conroy
Raquel E Gur
Christian G Kohler
Bruce I Turetsky
University of Pennsylvania · USTaste and Smell Clinic · US

Funding

Olfactory Evoked Potentials and Developmental Neuropathology in SchizophreniaR01MH059852 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI HAHN, CHANG-GYU, TURETSKY, BRUCE I · 1999 to 2015
$6.6M
Olfactory Function in Schizophrenia: A Lifespan AnalysisR01MH063381 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI MOBERG, PAUL J · 2002 to 2012
$3.9M
Neuroprotective/Neurodevelopmental Effects-Antipsychotics in Adolescent PsychosesK23MH079498 · NIMH · CHILDREN'S HOSP OF PHILADELPHIA · PI BORGMANN-WINTER, KARIN · 2010 to 2014
$819k
A Prospective Study of Endophenotypes in At-Risk Youths and Their SiblingsK08MH079364 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI CALKINS, MONICA E · 2007 to 2011
$750k
NIMH NIH HHS K08 MH079364NIMH NIH HHS K08MH79364NIMH NIH HHS K23 MH079498NIMH NIH HHS K23MH079498NIMH NIH HHS MH63381NIMH NIH HHS R01 MH059852NIMH NIH HHS R01 MH063381
6 · The paper itself

Abstract

backgroundWhile olfactory deficits have been reported in schizophrenia and youths at-risk for psychosis, few studies have linked these deficits to current pathophysiological models of the illness. There is evidence that disrupted cyclic adenosine 3',5'-monophosphate (cAMP) signaling may contribute to schizophrenia pathology. As cAMP mediates olfactory signal transduction, the degree to which this disruption could manifest in olfactory impairment was ascertained. Odor-detection thresholds to two odorants that differ in the degree to which they activate intracellular cAMP were assessed in clinical risk and low-risk participants.

methodBirhinal assessments of odor-detection threshold sensitivity to lyral and citralva were acquired in youths experiencing prodromal symptoms (n=17) and controls at low risk for developing psychosis (n=15). Citralva and lyral are odorants that differ in cAMP activation; citralva is a strong cAMP activator and lyral is a weak cAMP activator.

resultsThe overall group-by-odor interaction was statistically significant. At-risk youths showed significantly reduced odor detection thresholds for lyral, but showed intact detection thresholds for citralva. This odor-specific threshold deficit was uncorrelated with deficits in odor identification or discrimination, which were also present. ROC curve analysis revealed that olfactory performance correctly classified at-risk and low-risk youths with greater than 97% accuracy.

conclusionsThis study extends prior findings of an odor-specific hyposmia implicating cAMP-mediated signal transduction in schizophrenia and unaffected first-degree relatives to include youths at clinical risk for developing the disorder. These results suggest that dysregulation of cAMP signaling may be present during the psychosis prodrome.

Indexed as

OdorantsAdolescentAldehydesCell CommunicationCyclic AMPCyclohexenesFemaleHumansMaleNitrilesOlfaction DisordersOlfactory PerceptionPsychotic DisordersRiskSchizophreniaSensory ThresholdsAldehydescitralvaCyclic AMPCyclohexeneshydroxyisohexyl 3-cyclohexene carboxaldehydeNitriles

Identifiers

PMID22537567
PMCPMC3372687
OpenAlexW2079611565

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.